Role of important protein improves understanding of autoimmune diseases

22 Mar 2016, 4:59 p.m.

Genetic analyser for BRC

Researchers – led by Great Ormond Street BRC-supported Professor Tessa Crompton in collaboration with the Paediatric Department at Oxford University – have identified the role of a key protein in normal development of the thymus, an important organ of the immune system. The protein, known as Sonic hedgehog (SHH), is one of a few factors that regulate thymic epilthelial cell (TEC) differentiation and lineage choice. These findings contribute to our understanding of human autoimmune diseases and will inform strategies to replace thymus function in athymic children.

TECs are an essential component of the thymic stroma and are required to support T cell development. Two broad categories of TEC exist; medullary TECs, which are essential for the induction of tolerance to self, and cortical TECs, which are essential for T cell fate specification and T cell receptor repertoire selection. Researchers used both adult and foetal TECs to show that SHH regulates medullary TEC differentiation and function, with the potential to alter central tolerance.

These findings are important to our understanding of immunity, autoimmunity and immunodeficiency. In the future it will be important to assess the effects of SHH signalling on the induction and severity of human autoimmune diseases.

These findings were published in the Journal of Autoimmunity.

Fourth Annual NIHR GOSH BRC Image Competition - A Moment of Discovery

The Research and Innovation Communications team at GOSH and the NIHR GOSH Biomedical Research team invite you to enter our Research and Innovation Showcase: A Moment of Discovery.

New hope to prevent blindness in children with rare genetic disease

A new treatment that could prevent blindness in children with the CLN2 type Batten disease has been trialled by Clinicians at GOSH and University College London Great Ormond Street Institute of Child Health (UCL GOS ICH).

GOSH only hospital outside of North America to receive innovation funding award for AI

GOSH has been awarded the Amazon Web Services IMAGINE Grant: Children’s Health Innovation Award, to support artificial intelligence (AI) development and drive progress for children’s healthcare.

New clinical trial at GOSH gives hope to children with aggressive blood cancer

Researchers at GOSH and UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) are collaborating on a novel approach to clinical trials to give hope to children with an aggressive type of blood cancer, T-cell acute lymphoblastic leukaemia (T-ALL)